Allogeneic hematopoietic stem cell transplantation
Showing 51 - 75 of >10,000
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation Trial in Wuhan
Recruiting
- Acute Myeloid Leukemia, Adult
- +2 more
- Fludarabine and Busulfan
- Fludarabine and Melphalan
-
Wuhan, Hubei, ChinaWuhan Union Hospital, Tongji Medical college, Huazhong Universit
Jan 5, 2023
Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation Trial (Allogenic
Not yet recruiting
- Refractory Idiopathic Aplastic Anemia
- Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
- Allogenic transplantation
- (no location specified)
Nov 8, 2021
Hematologic Malignancy Trial in Chengdu (Allogeneic Hematopoietic Stem Cell Transplantation)
Recruiting
- Hematologic Malignancy
- Allogeneic Hematopoietic Stem Cell Transplantation
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Mar 12, 2022
Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)
Not yet recruiting
- Neuroblastoma
- Anti Thymocyte Globulin
- +10 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
Acute Myeloid Leukemia (AML) Relapse Trial in Freiburg, Münster (F16IL2, BI 836858)
Completed
- Acute Myeloid Leukemia (AML) Relapse
- F16IL2
- BI 836858
-
Freiburg, Germany
- +1 more
Apr 13, 2022
The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or
Recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Allogeneic Hematopoietic Stem Cell Transplantation
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022
Allogeneic Hematopoietic Stem Cell Transplantation Trial in Giza (chest physical therapy, routine medical treatment)
Completed
- Allogeneic Hematopoietic Stem Cell Transplantation
- chest physical therapy
- routine medical treatment
-
Giza, Nnjkjk, EgyptZizi Mohammed Ibrahim Ali
Oct 21, 2021
GVHD Trial in New York (Bortezomib, Cyclophosphamide)
Active, not recruiting
- GVHD
-
New York, New YorkNew York University School of Medicine
Apr 15, 2022
Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1
Terminated
- HIV-1 Infection
-
Sydney, New South Wales, AustraliaSt Vincent's Hospital
Oct 31, 2021
Acute Graft-versus-host Disease Trial in United States (Efmarodocokin Alfa)
Active, not recruiting
- Acute Graft-versus-host Disease
- Efmarodocokin Alfa
-
Duarte, California
- +7 more
Dec 6, 2022
Allo-HSCT as First-line Consolidation in High-risk PTCL
Recruiting
- T Cell Lymphoma
-
Beijing, ChinaPeking University People's Hospital
Jul 31, 2022
Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)
Completed
- Acute,Leukemia, Lymphoid
- Dasatinib
- +12 more
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Aug 2, 2022
Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)
Recruiting
- Leukemia, Myeloid, Acute
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Dec 27, 2022
The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD
Recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Allogeneic Hematopoietic Stem Cell Transplantation
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022
Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow
Recruiting
- Acute Myeloid Leukemia
- +3 more
- Fludarabine + Total Marrow Irradiation
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jun 1, 2022
Fungal Infection Trial in Shanghai (Escalating prophylaxis)
Recruiting
- Fungal Infection
- Escalating prophylaxis
-
Shanghai, Shanghai, ChinaBlood & Marrow Transplantation Center, RuiJin Hospital
Nov 23, 2021
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Leukemia/Lymphoma Trial in Milwaukee
Active, not recruiting
- Leukemia/Lymphoma
-
Milwaukee, WisconsinCIBMTR
Nov 17, 2021
Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C
Not yet recruiting
- Acute Myeloid Leukemia
- +4 more
- (no location specified)
Nov 1, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
HIV Trial in Baltimore (Enfuvirtide)
Completed
- HIV
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center
Nov 22, 2021
Allogeneic Hematopoietic Cell Transplantation Trial in Cincinnati (TCRaß+/CD19+ depleted allogeneic hematopoietic stem cell
Recruiting
- Allogeneic Hematopoietic Cell Transplantation
- TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplant (HSCT)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Sep 21, 2021
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh
Active, not recruiting
- Acute Myeloid Leukemia (AML)
- +2 more
- Reduced-Intensity Conditioning Regimen
- Myeloablative Conditioning Regimen
-
Pittsburgh, PennsylvaniaUPMC Children's Hospital of Pittsburgh
Jan 4, 2023